Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Bayer reports positive results for blood thinner after 2023 setback - 2Support Your Body: A Manual for Smart dieting and Sustenance
- 3Ukrainian Army Converts E38 BMW 7-Series Into Multiple Rocket Launch Platform
- 4Support Your Investment funds with These Individual accounting Thoughts
- 5Impact of NIH funding reductions felt in cancer and infectious disease trials
- Environmental groups urge Germany to cut oil and gas dependence
- Pick Your Top Method for starting the Morning
- Live long and loiter: Why NASA's ESCAPADE probes will wait a year in space before heading to Mars
- A mom stopped giving her kids snacks — and sparked a debate about eating habits
- Protester climbs on to balcony of Iranian embassy in London
- Figure out how to Use Your Brain research Degree in the Gig Market
- Find the Effect of Web-based Entertainment on Psychological wellness: Exploring the Advanced Scene Securely
- Hezbollah field commander killed in IDF strikes in Beirut
- A Manual for the Right SUV for Seniors
